C6 - LAI-only Buprenorphine Induction Protocol

Not giving away our shot! — Using long-acting medications for the treatment of OUD.

Substance use disorder remains a leading cause of preventable morbidity and mortality in the United States, with opioid- and alcohol-related overdoses continuing to strain behavioral health systems, emergency services, and families. MOUD is the life-saving, highly effective standard-of-care treatment for OUD, but problems with adherence and retention are considerable. This session will provide an overview of the use and benefits of long-acting injectable medication formulations including buprenorphine and naltrexone. Topics will include: evidence for LA formulations, approaches to implementation, practical clinical strategies and patient selection, advances in medication initiation techniques, clinical vignettes.